Segui
Joaquin (Quim) Madrenas
Joaquin (Quim) Madrenas
Professor of Medicine and Vice Dean for Faculty, David Geffen School of Medicine at UCLA
Nessuna email verificata
Titolo
Citata da
Citata da
Anno
A molecular perspective of CTLA-4 function
WA Teft, MG Kirchhof, J Madrenas
Annu. Rev. Immunol. 24, 65-97, 2006
6482006
ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists
J Madrenas, RL Wange, JL Wang, N Isakov, LE Samelson, RN Germain
Science 267 (5197), 515-518, 1995
6291995
Human embryonic stem cells possess immune‐privileged properties
L Li, ML Baroja, A Majumdar, K Chadwick, A Rouleau, L Gallacher, ...
Stem Cells 22 (4), 448-456, 2004
4382004
Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis
JD Spence, V Coates, H Li, A Tamayo, C Munoz, DG Hackam, M DiCicco, ...
Archives of neurology 67 (2), 180-186, 2010
4332010
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression
BM Carreno, F Bennett, TA Chau, V Ling, D Luxenberg, J Jussif, ...
The Journal of Immunology 165 (3), 1352-1356, 2000
3532000
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool
J Garcia‐Castro, C Trigueros, J Madrenas, JA Perez‐Simon, R Rodriguez, ...
Journal of cellular and molecular medicine 12 (6b), 2552-2565, 2008
2172008
Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality
A Gagnon, MS Miller, SA Hallman, R Bourbeau, DA Herring, DJD Earn, ...
PloS one 8 (8), e69586, 2013
2152013
The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide–MHC molecule ligands
J Madrenas, LA Chau, J Smith, JA Bluestone, RN Germain
The Journal of experimental medicine 185 (2), 219-230, 1997
2141997
Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications
GE Gardiner, C Heinemann, ML Baroja, AW Bruce, D Beuerman, ...
International Dairy Journal 12 (2-3), 191-196, 2002
1682002
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome
TA Chau, ML McCully, W Brintnell, G An, KJ Kasper, ED Vinés, P Kubes, ...
Nature medicine 15 (6), 641-648, 2009
1662009
The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i‐AAA protease YME1L
T Wai, S Saita, H Nolte, S Müller, T König, R Richter‐Dennerlein, ...
EMBO reports 17 (12), 1844-1856, 2016
1592016
Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function
DA Christie, CD Lemke, IM Elias, LA Chau, MG Kirchhof, B Li, EH Ball, ...
Molecular and cellular biology 31 (18), 3845-3856, 2011
1472011
Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Gα11-dependent, PLC-β-mediated pathway
C Bueno, CD Lemke, G Criado, ML Baroja, SSG Ferguson, ...
Immunity 25 (1), 67-78, 2006
1282006
Surface cytotoxic T lymphocyte–associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation
PJ Darlington, ML Baroja, TA Chau, E Siu, V Ling, BM Carreno, ...
The Journal of experimental medicine 195 (10), 1337-1347, 2002
1282002
Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A
ML Baroja, L Vijayakrishnan, E Bettelli, PJ Darlington, TA Chau, V Ling, ...
The Journal of Immunology 168 (10), 5070-5078, 2002
1242002
A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus
V Frodermann, TA Chau, S Sayedyahossein, JM Toth, DE Heinrichs, ...
Journal of infectious Diseases 204 (2), 253-262, 2011
1202011
Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation
RN Madrenas Joaquin, Germain
Seminars in immunology 8 (2), 83-101, 1996
1191996
Metalloproteinases Are Involved in Lipopolysaccharide–and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression
MH Khandaker, G Mitchell, L Xu, JD Andrews, R Singh, H Leung, ...
Blood, The Journal of the American Society of Hematology 93 (7), 2173-2185, 1999
1141999
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor
LA Chau, JA Bluestone, J Madrenas
The Journal of experimental medicine 187 (10), 1699-1709, 1998
1121998
The molecular immunology of acute rejection: an overview
PF Halloran, AP Broski, TD Batiuk, J Madrenas
Transplant immunology 1 (1), 3-27, 1993
1091993
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20